We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Beckman Coulter Genomics Offers Sequencing Services

By LabMedica International staff writers
Posted on 14 Aug 2009
Beckman Coulter (Fullerton, CA, USA) has formed Beckman Coulter Genomics (Beverly, MA, USA), combining the operations of its Agencourt Bioscience business with Cogenics, a firm it recently purchased.

Beckman Coulter Genomics will offer scientists genomic service resources with expanded global capabilities. It will provide a variety of services including sequencing, sample preparation, genotyping, gene expression, biologic efficiency and safety testing, as well as support for regulatory compliance including Clinical Laboratory Improvement Amendments (CLIA). In addition, it will offer nucleic acid purification products, thus serving both the life-science and pharmaceutical industries.

Richard Creager, Beckman Coulter group vice president of immunoassay, molecular diagnostics, and genomic services, stated, "Through the creation of Beckman Coulter Genomics, we have successfully brought together the industry's leading genomic service providers to offer our customers the highest-quality data and analysis."

Beckman Coulter, Inc., develops, manufactures, and markets products that simplify, automate, and develop complex biomedical tests.

Related Links:
Beckman Coulter
Beckman Coulter Genomics
Agencourt Bioscience
Cogenics


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Pipette Calibration System
Artel PCS®
Steam Sterilizer
Hi Vac II Line

Latest Molecular Diagnostics News

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation
14 Aug 2009  |   Molecular Diagnostics

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth
14 Aug 2009  |   Molecular Diagnostics

Liquid Biopsy Combines Multiple Signals for Cancer Detection in a Single Analysis
14 Aug 2009  |   Molecular Diagnostics